The impact of cord blood therapy in 2020

2020 is already proving to be a landmark year for many reasons, including within the field of regenerative medicine. While haematopoietic stem cells (HSCs) within cord blood can already treat 85 diseases and conditions, new therapies are being developed and trialled at an increasing pace thanks to advancements in stem cell research.

Did you know, there are currently around 1,500 clinical trials using the haematopoietic stem cells (HSCs) found in cord blood and mesenchymal stem cells (MSCs) found in cord tissue? As this number grows, more and more families are choosing cord blood banking for their children at birth. This valuable source of stem cells can provide a potential ‘lifeline’ in future treatments.

Exploring cord blood and its impact in various conditions